Skip to main content
PMC home page
Heart logoLink to Heart
. 1997 May;77(5):395–396. doi: 10.1136/hrt.77.5.395

Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.

G Y Lip 1
PMCID: PMC484756  PMID: 9196404

Full text

PDF
395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asakura H., Hifumi S., Jokaji H., Saito M., Kumabashiri I., Uotani C., Morishita E., Yamazaki M., Shibata K., Mizuhashi K. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagul Fibrinolysis. 1992 Aug;3(4):469–473. [PubMed] [Google Scholar]
  2. Black I. W., Chesterman C. N., Hopkins A. P., Lee L. C., Chong B. H., Walsh W. F. Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol. 1993 Feb;21(2):451–457. doi: 10.1016/0735-1097(93)90688-w. [DOI] [PubMed] [Google Scholar]
  3. Black I. W., Hopkins A. P., Lee L. C., Walsh W. F. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol. 1991 Aug;18(2):398–404. doi: 10.1016/0735-1097(91)90592-w. [DOI] [PubMed] [Google Scholar]
  4. Blann A. D., Waite M. A. von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis. Coron Artery Dis. 1996 Feb;7(2):143–147. doi: 10.1097/00019501-199602000-00008. [DOI] [PubMed] [Google Scholar]
  5. Daniel W. G., Nellessen U., Schröder E., Nonnast-Daniel B., Bednarski P., Nikutta P., Lichtlen P. R. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol. 1988 Jun;11(6):1204–1211. doi: 10.1016/0735-1097(88)90283-5. [DOI] [PubMed] [Google Scholar]
  6. Fatkin D., Herbert E., Feneley M. P. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol. 1994 Apr 1;73(9):672–676. doi: 10.1016/0002-9149(94)90932-6. [DOI] [PubMed] [Google Scholar]
  7. Fowkes F. G., Lowe G. D., Housley E., Rattray A., Rumley A., Elton R. A., MacGregor I. R., Dawes J. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet. 1993 Jul 10;342(8863):84–86. doi: 10.1016/0140-6736(93)91288-w. [DOI] [PubMed] [Google Scholar]
  8. Heppell R. M., Berkin K. E., McLenachan J. M., Davies J. A. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart. 1997 May;77(5):407–411. doi: 10.1136/hrt.77.5.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jansson J. H., Nilsson T. K., Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991 Nov;66(5):351–355. doi: 10.1136/hrt.66.5.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kumagai K., Fukunami M., Ohmori M., Kitabatake A., Kamada T., Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol. 1990 Aug;16(2):377–380. doi: 10.1016/0735-1097(90)90589-h. [DOI] [PubMed] [Google Scholar]
  11. Lip G. Y. Does atrial fibrillation confer a hypercoagulable state? Lancet. 1995 Nov 18;346(8986):1313–1314. doi: 10.1016/s0140-6736(95)92339-x. [DOI] [PubMed] [Google Scholar]
  12. Lip G. Y., Lip P. L., Zarifis J., Watson R. D., Bareford D., Lowe G. D., Beevers D. G. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation. 1996 Aug 1;94(3):425–431. doi: 10.1161/01.cir.94.3.425. [DOI] [PubMed] [Google Scholar]
  13. Lip G. Y., Lowe G. D. ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation. BMJ. 1996 Jan 6;312(7022):45–49. doi: 10.1136/bmj.312.7022.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lip G. Y., Lowe G. D., Rumley A., Dunn F. G. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J. 1996 Apr;131(4):724–730. doi: 10.1016/s0002-8703(96)90278-1. [DOI] [PubMed] [Google Scholar]
  15. Lip G. Y., Lowe G. D., Rumley A., Dunn F. G. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J. 1995 Jun;73(6):527–533. doi: 10.1136/hrt.73.6.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lip G. Y., Rumley A., Dunn F. G., Lowe G. D. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm. Int J Cardiol. 1995 Oct;51(3):245–251. doi: 10.1016/0167-5273(95)02434-x. [DOI] [PubMed] [Google Scholar]
  17. Mitusch R., Garbe M., Schmücker G., Schwabe K., Stierle U., Sheikhzadeh A. Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. Am J Cardiol. 1995 May 1;75(14):944–947. doi: 10.1016/s0002-9149(99)80695-x. [DOI] [PubMed] [Google Scholar]
  18. Mitusch R., Siemens H. J., Garbe M., Wagner T., Sheikhzadeh A., Diederich K. W. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost. 1996 Feb;75(2):219–223. [PubMed] [Google Scholar]
  19. Mügge A., Kühn H., Nikutta P., Grote J., Lopez J. A., Daniel W. G. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol. 1994 Mar 1;23(3):599–607. doi: 10.1016/0735-1097(94)90743-9. [DOI] [PubMed] [Google Scholar]
  20. Obarski T. P., Salcedo E. E., Castle L. W., Stewart W. J. Spontaneous echo contrast in the left atrium during paroxysmal atrial fibrillation. Am Heart J. 1990 Oct;120(4):988–990. doi: 10.1016/0002-8703(90)90224-l. [DOI] [PubMed] [Google Scholar]
  21. Peverill R. E., Harper R. W., Gelman J., Gan T. E., Harris G., Smolich J. J. Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis. Circulation. 1996 Aug 1;94(3):331–339. doi: 10.1161/01.cir.94.3.331. [DOI] [PubMed] [Google Scholar]
  22. Ridker P. M., Hennekens C. H., Cerskus A., Stampfer M. J. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 1994 Nov;90(5):2236–2240. doi: 10.1161/01.cir.90.5.2236. [DOI] [PubMed] [Google Scholar]
  23. Rowbotham B. J., Whitaker A. N., Harrison J., Murtaugh P., Reasbeck P., Bowie E. J. Measurement of crosslinked fibrin derivatives in patients undergoing abdominal surgery: use in the diagnosis of postoperative venous thrombosis. Blood Coagul Fibrinolysis. 1992 Feb;3(1):25–31. doi: 10.1097/00001721-199202000-00005. [DOI] [PubMed] [Google Scholar]
  24. Sohara H., Amitani S., Kurose M., Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1997 Jan;29(1):106–112. doi: 10.1016/s0735-1097(96)00427-5. [DOI] [PubMed] [Google Scholar]
  25. Tsai L. M., Chen J. H., Fang C. J., Lin L. J., Kwan C. M. Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol. 1992 Aug 1;70(3):327–331. doi: 10.1016/0002-9149(92)90613-4. [DOI] [PubMed] [Google Scholar]
  26. Yamamoto K., Ikeda U., Seino Y., Mito H., Fujikawa H., Sekiguchi H., Shimada K. Coagulation activity is increased in the left atrium of patients with mitral stenosis. J Am Coll Cardiol. 1995 Jan;25(1):107–112. doi: 10.1016/0735-1097(94)00322-h. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES